We are happy to welcome Dr. Franziska Blaeschke from the KiTZ for a talk on “Modular Pooled Knockin Screens: Reprogramming Therapeutic T Cells” at TRON!

Dr. Blaeschke is Junior Research Group leader at the Pediatric Immuno Oncology of the Hopp Children’s Cancer Center Heidelberg (KiTZ), which is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and Heidelberg University. Her team uses high-throughput CRISPR screens to  develop the next generation of cellular therapies for pediatric cancer patients.

Read more about her research here: JRG Pediatric Immuno-Oncology - Hopp-Kindertumorzentrum Heidelberg - KiTZ